Financials

  • Market Capitalization 280.02 M
  • Employee 122
  • Founded 2020
  • CEO N/A
  • Website www.invivyd.com
  • Headquarter Delaware, United States
  • FIGI BBG00W4ML039
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-2.81
Relación precio/flujo de caja
3.28

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
3370
RNAC
Cartesian Therapeutics, Inc. - Common Stock
9.28 USD-3.33%-8.93%+17.62%+1.31%280.77 M USD
3371
LCTX
Lineage Cell Therapeutics, Inc. Common Stock
1.11 USD-0.89%+2.78%+1.83%-35.35%280.73 M USD
3396
TRDA
Entrada Therapeutics, Inc. - Common Stock
7.05 USD+0.71%-4.60%+3.22%+1.15%274.50 M USD
3400
SION
Sionna Therapeutics, Inc. - Common Stock
6.03 USD+2.73%+7.68%-87.13%-84.67%272.63 M USD

Noticias